Author: admin

The 2022 Society for Benefit-Cost Analysis annual conference will feature research conducted by several CHDS research teams. For example, Lisa Robinson, CHDS Deputy Director and Senior

CHDS PhD candidate John Giardina published an article in JAMA Network Open on “off-ramps” and “on-ramps” for masking and other COVID-19 transmission mitigation

Jagpreet Chhatwal presented a suite of COVID-19 simulation tools at the January 18, 2022, CHDS seminar. Chhatwal is the Associate Director of the MGH Institute for Technology Assessment and Assistant

Recently published research by CHDS’ Yuli (Lily) Hsieh and colleagues evaluated the effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States. When

CHDS faculty James Hammitt will direct his annual risk analysis course on February 28 through March 4, 2022. The course is designed for professionals and academics, including graduate students,

CHDS deputy director Lisa A. Robinson received the Outstanding Practitioner Award at the December 2021 Society for Risk Analysis (SRA) Annual Meeting. The award recognizes a member of the Society

CHDS faculty Stéphane Verguet has been promoted to Associate Professor of Global Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health.

CHDS faculty Eve Wittenberg discussed how families can use decision analytic methods in the real-world context of making Thanksgiving travel plans during the second holiday season of the pandemic.

The 43rd Annual Meeting of the Society for Medical Decision Making (SMDM) was conducted virtually and included contributions by CHDS faculty, postdocs, and students. CHDS

CHDS’ Thomas Gaziano and Shafika Abrahams-Gessel’s analysis on the health impact and cost-effectiveness of achieving the National Salt and Sugar Reduction Initiative (NSSRI)